GalR3 activation promotes adult neural stem cell survival in response to a diabetic milieu

Shiva Mansouri1, Swapnali Barde, Henrik Ortsäter

  • 1Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden.

Insights

Type 2 diabetes harms brain stem cells. Galanin receptor 3 activation protects these cells by reducing apoptosis and the unfolded protein response, offering potential therapeutic strategies for brain disorders.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Cell Biology

Background:

  • Type 2 diabetes is linked to central nervous system complications.
  • Adult neurogenesis impairment is a potential contributor to these complications.
  • Galanin's role in protecting neural stem cells (NSCs) from glucolipotoxicity is unexplored.

Purpose of the Study:

  • To investigate galanin's protective role in adult neural stem cells (NSCs) against glucolipotoxicity.
  • To determine the involvement of apoptosis and the unfolded protein response in galanin's effects.
  • To analyze the regulation of galanin and its receptor subtypes in diabetes.

Main Methods:

  • Assessed viability of mouse subventricular zone (SVZ)-derived NSCs under glucolipotoxic conditions.
  • Evaluated apoptosis markers (Bcl-2, cleaved caspase-3) and unfolded protein response pathways (CHOP, GRP78/BiP, XBP1, JNK phosphorylation).
  • Examined galanin and receptor subtype regulation in NSCs in vitro and SVZ tissues from normal and type 2 diabetic mice.

Main Results:

  • Galanin receptor (GalR)3 activation significantly increased NSC viability.
  • This neuroprotection was associated with reduced apoptosis and C/EBP homologous protein (CHOP) levels.
  • Diabetes differentially regulated galanin and its receptor subtypes in NSCs both in vitro and in vivo.

Conclusions:

  • Galanin receptor 3 activation mediates neuroprotection against glucolipotoxicity.
  • This pathway offers a potential therapeutic target for treating brain disorders associated with diabetes.
  • Understanding galanin's role provides insights into managing CNS complications of type 2 diabetes.